A Randomized, Comparative Study to Evaluate Efficacy and Safety of Two Injection Volumes of AbobotulinumtoxinA in Treatment of Glabellar Lines

被引:12
|
作者
Punga, Anna Rostedt [1 ]
Alimohammadi, Mohammad [2 ]
Fagrell, Dan [3 ]
Nyberg, Frida [4 ]
Rees, Diane [5 ]
Wong, Cindy [4 ]
机构
[1] Uppsala Univ, Dept Neurosci, Husargatan 3, S-75124 Uppsala, Sweden
[2] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[3] Goteborgs Plastikkirurgiska Ctr, Gothenburg, Sweden
[4] Galderma A&C, Uppsala, Sweden
[5] Zenith Healthcare Commun Ltd, Chester, Cheshire, England
关键词
TOXIN TYPE-A; DOUBLE-BLIND; BOTULINUM; DIFFUSION; RHYTIDES;
D O I
10.1097/DSS.0000000000000805
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUNDDifferent volumes of 0.9% NaCl may be used to reconstitute abobotulinumtoxinA yielding an injection volume that ranges from 0.05 to 0.1 mL per injection point for treatment of glabellar lines.OBJECTIVETo evaluate the efficacy, safety, and subject satisfaction of 2 different injection volumes to deliver the same unit dose of abobotulinumtoxinA for treatment of glabellar lines.MATERIALS AND METHODSThis randomized comparative study was conducted using 2 different reconstitution volumes to deliver a fixed unit dose of 10 Speywood units (sU) of abobotulinumtoxinA in either 0.05 mL (labeled volume) or 0.1 mL (twofold volume) per injection point. Evaluations included wrinkle severity, neurophysiological assessment by compound muscle action potential (CMAP), and subject satisfaction.RESULTSUse of either injection volume of abobotulinumtoxinA resulted in the early onset of effect, high effectiveness, and long duration of effect. The safety profile and injection pain levels were similar in both groups. The twofold injection volume was shown to be noninferior to the labeled injection volume based on CMAP results.CONCLUSIONA twofold increase in injection volume to 0.1 mL per injection point to deliver 10 sU of abobotulinumtoxinA is effective and safe.
引用
收藏
页码:967 / 976
页数:10
相关论文
共 50 条
  • [1] Clinical Assessment of 2 Licensed AbobotulinumtoxinA Injection Volumes for the Treatment of Glabellar Lines
    Kaufman, Joely
    Cohen, Joel L.
    Peredo, Marina I.
    Jonas, Brandie
    Down, Rebecca
    Nogueira, Alessandra
    DERMATOLOGIC SURGERY, 2019, 45 (10) : 1274 - 1284
  • [2] Efficacy and safety of two injection volumes of abobotulinumtoxin-A in treatment of glabellar lines: Data from two studies
    Kaufman-Janette, Joely
    Andriopoulos, Bill
    Nogueira, Alessandra
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB137 - AB137
  • [3] Two on-label injection volumes of abobotulinumtoxinA produce similar safety and efficacy results when used to treat moderate to severe glabellar lines
    Kaufman, Joely
    Cohen, Joel
    Peredo, Marina
    Peredo, Marina I.
    Nogueira, Alessandra
    Mashburn, Jay
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB305 - AB305
  • [4] A Multicenter Study to Evaluate Subject Satisfaction With Two Treatments of AbobotulinumtoxinA a Year in the Glabellar Lines
    Schlessinger, Joel
    Cohen, Joel L.
    Shamban, Ava
    Jacob, Carolyn
    Karimi, Kian
    Maas, Corey
    Lane, Vanessa
    Coquis-Knezek, Sarah
    Meckfessel, Matthew
    DERMATOLOGIC SURGERY, 2021, 47 (04) : 504 - 509
  • [5] Efficacy, Safety, and Subject Satisfaction After AbobotulinumtoxinA Treatment for Moderate to Severe Glabellar Lines
    Monheit, Gary D.
    Baumann, Leslie
    Maas, Corey
    Rand, Rhonda
    Down, Rebecca
    DERMATOLOGIC SURGERY, 2020, 46 (01) : 61 - 69
  • [6] Efficacy and Safety of AbobotulinumtoxinA for Treatment of Moderate-to-Severe Glabellar Lines: A Meta-Analysis
    Han, Xiaopan
    Bai, Jixian
    Kuang, Jing
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (02): : 126 - 133
  • [7] A randomized, dose-escalating, double-blind study to evaluate abobotulinumtoxinA for the treatment of moderate-to-severe glabellar lines
    Joseph, John
    Moradi, Amir
    Lorenc, Z. Paul
    Coleman, Kyle
    Ablon, Glynis
    Kaufman-Janette, Joely
    Cox, Sue Ellen
    Campbell, Andrew
    Dayan, Steven
    Munavalli, Girish
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB69 - AB69
  • [8] AbobotulinumtoxinA Treatment of Glabellar Lines Using a New Reconstitution and Injection Volume: Randomized, Placebo-Controlled Data
    Schlessinger, Joel
    Friedmann, Daniel P.
    Mayoral, Flor
    Robinson, Deanne Mraz
    Glaser, DeeAnna
    Wu, Douglas
    Marcus, Keith
    Somenek, Michael
    Lin, Xiaoming
    JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (09) : 988 - 995
  • [9] Subject satisfaction demonstrated for two on-label injection volumes of abobotulinumtoxinA when used to treat moderate to severe glabellar lines
    Cohen, Joel
    Kaufman, Joely
    Peredo, Marina
    Peredo, Marina I.
    Jonas, Brandie
    Nogueira, Alessandra
    Mashburn, Jay
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB272 - AB272
  • [10] Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
    Wu, Yan
    Fang, Fang
    Lai, Wei
    Li, Chengxin
    Li, Li
    Liu, Quanzhong
    Lu, Jianyun
    Pang, Xiaowen
    Sun, Jiaming
    Shi, Xiaofeng
    Picaut, Philippe
    Prygova, Inna
    Andriopoulos, Bill
    Sun, Qiuning
    AESTHETIC PLASTIC SURGERY, 2023, 47 (01) : 351 - 364